Bevacizumab for CRVO Associated CME: Effect of Timing and Frequency of Injections on Final Visual Outcome

Table 2

Mean change of visual acuity by the time from the CRVO event to the first Avastin injection and the regimen of injections administered.

Number and timing of injections	Mean primary visual acuity	Mean final visual acuity	Change in mean visual acuity
1 injection within 1 month	0.075	0.166	0.091
1 injection within 2 months	0.05	0.18	0.058
1 injection within 3 months	0.05	0.072	0.022
1 injection after more than 3 months	0.02	0.02	0.00
3 injections beginning within 1 month	0.05	0.193	0.143
3 injections beginning within 2 months	0.075	0.168	0.093
3 injections beginning within 3 months	0.04	0.091	0.051
3 injections beginning after more than 3 months	0.02	0.017	−0.003